Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant

por Gordon, David L., Sajkov, Dimitar, Honda-Okubo, Yoshikazu, Wilks, Samuel H., Aban, Malet, Barr, Ian G., Petrovsky, Nikolai
Publicado 2016

Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography

por Rössler, Annika, Netzl, Antonia, Knabl, Ludwig, Bante, David, Wilks, Samuel H., Borena, Wegene, von Laer, Dorothee, Smith, Derek J., Kimpel, Janine
Publicado 2023

Antigenic Maps of Influenza A(H3N2) Produced With Human Antisera Obtained After Primary Infection

por Fonville, Judith M., Fraaij, Pieter L. A., de Mutsert, Gerrie, Wilks, Samuel H., van Beek, Ruud, Fouchier, Ron A. M., Rimmelzwaan, Guus F.
Publicado 2016

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants

por Rössler, Annika, Netzl, Antonia, Knabl, Ludwig, Schäfer, Helena, Wilks, Samuel H., Bante, David, Falkensammer, Barbara, Borena, Wegene, von Laer, Dorothee, Smith, Derek J., Kimpel, Janine
Publicado 2022

Characterization of A/H7 influenza virus global antigenic diversity and key determinants in the hemagglutinin globular head mediating A/H7N9 antigenic evolution

por Kok, Adinda, Scheuer, Rachel, Bestebroer, Theo M., Burke, David F., Wilks, Samuel H., Spronken, Monique I., de Meulder, Dennis, Lexmond, Pascal, Pronk, Mark, Smith, Derek J., Herfst, Sander, Fouchier, Ron A. M., Richard, Mathilde
Publicado 2023

Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains

por Ying, Baoling, Whitener, Bradley, VanBlargan, Laura A., Hassan, Ahmed O., Shrihari, Swathi, Liang, Chieh-Yu, Karl, Courtney E., Mackin, Samantha, Chen, Rita E., Kafai, Natasha M., Wilks, Samuel H., Smith, Derek J., Carreño, Juan Manuel, Singh, Gagandeep, Krammer, Florian, Carfi, Andrea, Elbashir, Sayda, Edwards, Darin K., Thackray, Larissa B., Diamond, Michael S.
Publicado 2021

Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains

por Ying, Baoling, Whitener, Bradley, VanBlargan, Laura A., Hassan, Ahmed O., Shrihari, Swathi, Liang, Chieh-Yu, Karl, Courtney E., Mackin, Samantha, Chen, Rita E., Kafai, Natasha M., Wilks, Samuel H., Smith, Derek J., Carreño, Juan Manuel, Singh, Gagandeep, Krammer, Florian, Carfi, Andrea, Elbashir, Sayda M., Edwards, Darin K., Thackray, Larissa B., Diamond, Michael S.
Publicado 2021

Mapping SARS-CoV-2 antigenic relationships and serological responses

por Wilks, Samuel H., Mühlemann, Barbara, Shen, Xiaoying, Türeli, Sina, LeGresley, Eric B., Netzl, Antonia, Caniza, Miguela A., Chacaltana-Huarcaya, Jesus N., Corman, Victor M., Daniell, Xiaoju, Datto, Michael B., Dawood, Fatimah S., Denny, Thomas N., Drosten, Christian, Fouchier, Ron A. M., Garcia, Patricia J., Halfmann, Peter J., Jassem, Agatha, Jeworowski, Lara M., Jones, Terry C., Kawaoka, Yoshihiro, Krammer, Florian, McDanal, Charlene, Pajon, Rolando, Simon, Viviana, Stockwell, Melissa S., Tang, Haili, van Bakel, Harm, Veguilla, Vic, Webby, Richard, Montefiori, David C., Smith, Derek J.
Publicado 2023

Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera

por Mühlemann, Barbara, Wilks, Samuel H, Baracco, Lauren, Bekliz, Meriem, Carreño, Juan Manuel, Corman, Victor M, Davis-Gardner, Meredith E., Dejnirattisai, Wanwisa, Diamond, Michael S, Douek, Daniel C., Drosten, Christian, Eckerle, Isabella, Edara, Venkata-Viswanadh, Ellis, Madison, Fouchier, Ron A M, Frieman, Matthew, Godbole, Sucheta, Haagmans, Bart, Halfmann, Peter J, Henry, Amy R, Jones, Terry C, Katzelnick, Leah C, Kawaoka, Yoshihiro, Kimpel, Janine, Krammer, Florian, Lai, Lilin, Liu, Chang, Lusvarghi, Sabrina, Meyer, Benjamin, Mongkolsapaya, Juthathip, Montefiori, David C, Mykytyn, Anna, Netzl, Antonia, Pollett, Simon, Rössler, Annika, Screaton, Gavin R, Shen, Xiaoying, Sigal, Alex, Simon, Viviana, Subramanian, Rahul, Supasa, Piyada, Suthar, Mehul, Türeli, Sina, Wang, Wei, Weiss, Carol D, Smith, Derek J
Publicado 2023

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial

por Branche, Angela R., Rouphael, Nadine G., Diemert, David J., Falsey, Ann R., Losada, Cecilia, Baden, Lindsey R., Frey, Sharon E., Whitaker, Jennifer A., Little, Susan J., Anderson, Evan J., Walter, Emmanuel B., Novak, Richard M., Rupp, Richard, Jackson, Lisa A., Babu, Tara M., Kottkamp, Angelica C., Luetkemeyer, Anne F., Immergluck, Lilly C., Presti, Rachel M., Bäcker, Martín, Winokur, Patricia L., Mahgoub, Siham M., Goepfert, Paul A., Fusco, Dahlene N., Malkin, Elissa, Bethony, Jeffrey M., Walsh, Edward E., Graciaa, Daniel S., Samaha, Hady, Sherman, Amy C., Walsh, Stephen R., Abate, Getahun, Oikonomopoulou, Zacharoula, El Sahly, Hana M., Martin, Thomas C. S., Kamidani, Satoshi, Smith, Michael J., Ladner, Benjamin G., Porterfield, Laura, Dunstan, Maya, Wald, Anna, Davis, Tamia, Atmar, Robert L., Mulligan, Mark J., Lyke, Kirsten E., Posavad, Christine M., Meagher, Megan A., Stephens, David S., Neuzil, Kathleen M., Abebe, Kuleni, Hill, Heather, Albert, Jim, Telu, Kalyani, Mu, Jinjian, Lewis, Teri C., Giebeig, Lisa A., Eaton, Amanda, Netzl, Antonia, Wilks, Samuel H., Türeli, Sina, Makhene, Mamodikoe, Crandon, Sonja, Montefiori, David C., Makowski, Mat, Smith, Derek J., Nayak, Seema U., Roberts, Paul C., Beigel, John H.
Publicado 2023